Patricia Castano-Santofimia
INSERM U1068, CNRS UMR 7258, 163 Avenue De Luminy
Marseille, 13288, France
Marseille, 13288, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
The ferroptosis inhibitor NUPR1 coordinates the mitochondrial response to oxidative stress and cell metabolism during COPD pathogenesis in the lung.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: August 20, 2026
Stress granules confer an early vulnerability in KRAS-driven pancreatic tumorigenesis.
Journal: Cell reports
Published: March 13, 2026
Nuclear protein 1 is a cell death regulator in primary human airway epithelial cells and reduced in idiopathic pulmonary fibrosis.
Journal: Scientific reports
Published: November 28, 2025
Evaluating the therapeutic role of salvianolic acid A on pancreatic cancer cells through interaction with the intrinsically disordered protein NUPR1.
Journal: International journal of biological macromolecules
Published: August 21, 2025
Oncogenic stress response mechanisms as new therapeutic targets in cancer treatment: A review.
Journal: Medicine
Published: June 17, 2025
Organosilicon molecules bind to the intrinsically disordered protein NUPR1 by clamping its hot-spots.
Journal: Archives of biochemistry and biophysics
Published: May 07, 2025
The mitochondrial catastrophe induced by NUPR1 inhibitors as a novel strategy to fight against cancer.
Journal: Critical reviews in oncology/hematology
Published: April 15, 2025
Mechanisms of induced resistance to the antitumoral agent ZZW-115 in pancreas ductal adenocarcinoma.
Mechanisms of induced resistance to the antitumoral agent ZZW-115 in pancreas ductal adenocarcinoma.
Journal: Scientific reports
Published: April 08, 2025
Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 02, 2025
The intrinsically disordered protein NUPR1 binds to phospholipids.
Journal: Protein science : a publication of the Protein Society
Published: March 13, 2025
Synergistic antitumor activity of sorafenib and the NUPR1 inhibitor LZX-2-73 in multiple cancer models.
Journal: Cell death & disease
Published: March 12, 2025
Last Updated: 09/26/2026